Today: 29 June 2026
Browse Category

NSE:CORR 15 December 2025

Corona Remedies Share Price Today (15 Dec 2025): Pharma Stock Debuts at 38% Premium After ₹655-Crore IPO — Latest News, Forecasts, Valuation and Analyst Views

Corona Remedies Share Price Today (15 Dec 2025): Pharma Stock Debuts at 38% Premium After ₹655-Crore IPO — Latest News, Forecasts, Valuation and Analyst Views

Corona Remedies shares debuted at ₹1,470 on NSE, a 38% premium to the IPO price of ₹1,062. The stock surged intraday to nearly ₹1,499 and hovered around the mid-₹1,460s by early afternoon, valuing the company near ₹9,000 crore. Trading volumes reached millions of shares. The listing beat grey market forecasts, which had predicted a 28–32% premium.
15 December 2025

Stock Market Today

  • Dart Mining Insiders Buy AU$827.5k in Shares Despite 19% Drop, Market Value Falls AU$786k
    June 28, 2026, 6:42 PM EDT. Dart Mining NL (ASX:DTM) insiders invested AU$827.5k in shares over the past year at an average price of AU$0.031 despite the stock dropping 19%, causing their holdings' market value to slump to AU$344.5k. Notably, insider Peter Arvanitis purchased AU$678k worth at about AU$0.026 per share, above the current AU$0.013 market price, signaling confidence. No insider sales were recorded. Insiders now control approximately 18% of the company, valued at AU$598k. The insider buying amid a share price decline suggests belief in future recovery, highlighting the importance of monitoring insider activity as a gauge of management sentiment.

Latest articles

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026
IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.
Go toTop